Table 1

Disposition of Kidney Transplant Recipients Patients receiving Tacrolimus combined with Three Different Doses of FK778 or with MMF
High level FK778 Mid level FK778 Low level FK778 MMF Total
Intent to treat population (ITT) 87 (100) 92 (100) 92 (100) 93 (100) 364 (100)
Completed study 50 (57.5) 59 (64.1) 71 (77.2) 71 (76.3) 251 (69)
Reasons for study withdrawal:
 Death 0 1 (1.1) 0 0 1 (0.3)
 Graft loss/retransplantation 1 (1.1) 1 (1.1) 3 (3.3) 2 (2.2) 7 (1.9)
 Adverse event 25 (28.7) 19 (20.7) 14 (15.2) 12 (12.9) 70 (19.2)
 Informed consent withdrawn 4 (4.6) 3 (3.3) 2 (2.2) 1 (1.1) 10 (2.7)
 Prohibited medication 3 (3.4) 5 (5.4) 0 1 (1.1) 9 (2.5)
 Other 4 (4.6) 4 (4.3) 2 (2.2) 6 (6.5) 16 (4.4)

Data are presented as number (percentage).

Wlodarczyk et al.

Wlodarczyk et al. BMC Nephrology 2012 13:68   doi:10.1186/1471-2369-13-68

Open Data